NCT03328494View on ClinicalTrials.gov

Study of Paclitaxel in Combination With BOS172722 in Patients With Advanced Nonhaematologic Malignancies

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

October 13, 2017

Primary Completion Date

March 16, 2021

Study Completion Date

March 16, 2021

Conditions
Advanced Nonhaematologic Malignancies
Interventions
DRUG

BOS172722

Oral capsules

DRUG

Paclitaxel

IV infusion

Trial Locations (3)

Unknown

Addenbrooks Hospital, Cambridge

Edinburgh Cancer Centre - Western General Hospital, Edinburgh

SM2 5NG

Royal Marsden, London

Sponsors
All Listed Sponsors
lead

Boston Pharmaceuticals

INDUSTRY